Stay updated on Sabatolimab Combo in MDS: Clinical Trial
Sign up to get notified when there's something new on the Sabatolimab Combo in MDS: Clinical Trial page.

Latest updates to the Sabatolimab Combo in MDS: Clinical Trial page
- Check7 days agoChange Detected- The page now states that the study was stopped by sponsor decision and is terminated as of 2025-10-09, with recruitment/status updated accordingly. - The previous status of 'Completed' with date 2025-04-01 has been removed.SummaryDifference4%
- Check14 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference10%
- Check21 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.2%
- Check28 days agoNo Change Detected
- Check36 days agoChange DetectedThe page revision was bumped from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed.SummaryDifference0.6%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.6%
- Check50 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. These changes enhance the clarity and relevance of the page's core content.SummaryDifference39%
Stay in the know with updates to Sabatolimab Combo in MDS: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sabatolimab Combo in MDS: Clinical Trial page.